Investigation of antimicrobial use pattern in the intensive treatment unit of a teaching hospital in western Nepal

American Journal of Infection Control

Volumn 31, Issue 7, 2003, Pages 410-414

  Shankar, P Ravi ^a,b   Partha, Praveen ^a   Shenoy, Nagesh ^a   Brahmadathan, K N ^a  

^a MANIPAL TEACHING HOSPITAL   (Nepal)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AMPICILLIN PLUS CLOXACILLIN; ANTIINFECTIVE AGENT; CEFALEXIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MACROLIDE; METRONIDAZOLE; NORFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NEPAL; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0242523760     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2003.57     Document Type: Article

References (15)

1. Marschner JP, Thurmann P, Harder S, Rietbrock N. Drug utilization review on a surgical intensive care unit. Int J Clin Pharmacol Ther 1994;32:447-51.
2. Kuruvilla A, George K, Rajaratnam A, John KR. Prescription patterns and cost analysis of drugs in a base hospital in South India. Natl Med J India 1994;7:167-8.
3. Tepper J, Schafer R, Hoffmann A. Analysis of amount, expenditures and indications of drug and blood product prescriptions at surgical intensive care units. Int J Clin Pharmacol Ther 1995;33:685-8.
4. Srishyla MV, Nagarani MA, Venkataraman BV. Drug utilization of antimicrobials in the in-patient setting of a tertiary hospital. Indian J Pharmacol 1994;26:282-7.
5. Bordeen LA, Butt W. Drug errors in intensive care. J Paediatr Child Health 1992;28:309-11.
6. Gupta N, Sharma D, Garg SK, Bhargava VK. Auditing of prescriptions to study antimicrobials in a tertiary hospital. Indian J Pharmacol 1997;29:411-5.
7. Mashford ML. Update-Victorian Medical Postgraduate Foundation Group. Aust J Hosp Pharm 1988;18(suppl):17-8.
8. Department of Drug Administration, Nepal. National list of essential drugs, Nepal 1997, 2nd ed. Department of Drug Administration, His Majesty's Government of Nepal.
9. Burke JP, Pestotnik SL. Antibiotic use and microbial resistance in intensive care units: impact of computer-assisted decision support. J Chemother 1999;11:530-5.
10. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leuw PW, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997;39: 527-35.
11. Bellomo R, Bersten AD, Boots RJ, Bristow PJ, Dobb GJ, Finfer SR, et al. The use of antimicrobials in ten Australian and New Zealand intensive care units: the Australian and New Zealand intensive care multicentre studies group investigators. Anaesth Intensive Care 1998; 26:648-53.
12. Borderon JC, Laugier J, Ramponi N, Saliba E, Gold F, Blond MH. Surveillance of antibiotic therapy in a pediatric intensive care unit. Ann Pediatr Paris 1992;39:27-36.
13. Moss F, McNeil MW, McSwiggan DA, Miller DL. Survey of antibiotic prescribing in a district general hospital. Lancet 1981;2:349-52.
14. Glupczynski Y, Delmme H, Goossens H, Struelens M. A multicentre study of antimicrobial resistance in gram-negative bacteria isolated from Belgian intensive care units in 1994-1995: Belgian multicentre ICU study group. Acta Clin Belg 1998:53:28-33.
15. Rotimi VO, al Sweih NA, Feteih J. The prevalence and antibiotic susceptibility pattern of gram-negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diagn Microbiol Infect Dis 1998; 30:53-9.